Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
6 this month

Showing 21–40 of 17,529 recalls

February 5, 2026· Fresenius Kabi Compounding, LLC

Recalled Item: ketamine HCl

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 5, 2026· Fresenius Kabi Compounding, LLC

Recalled Item: vancomycin HCl

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 5, 2026· Fresenius Kabi Compounding, LLC

Recalled Item: vancomycin HCl

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 5, 2026· Fresenius Kabi Compounding, LLC

Recalled Item: acyclovir sodium

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 2, 2026· Pro Numb Tattoo Numbing Spray LLC

Recalled Item: Pro Numb Tattoo Numbing Spray

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 2, 2026· Pro Numb Tattoo Numbing Spray LLC

Recalled Item: Pro Numb Tattoo Numbing Spray

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2026· Teva Pharmaceuticals USA, Inc

Recalled Item: Metoprolol Succinate Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2026· Teva Pharmaceuticals USA, Inc

Recalled Item: Metoprolol Succinate Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2026· Teva Pharmaceuticals USA, Inc

Recalled Item: Metoprolol Succinate Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 29, 2026· Teva Pharmaceuticals USA, Inc

Recalled Item: Metoprolol Succinate Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 27, 2026· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Diclofenac Sodium

The Issue: Failed Viscosity Specifications: Out of Specification (OOS) [slightly

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 26, 2026· Radnostix

Recalled Item: Sodium Iodide (I-131) Solution

The Issue: Presence of Particulate Matter: Due to production issues

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 26, 2026· F.H. INVESTMENTS, Inc. (dba Asteria Health)

Recalled Item: Testosterone

The Issue: Presence of Foreign substance - potential presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 26, 2026· F.H. INVESTMENTS, Inc. (dba Asteria Health)

Recalled Item: Testosterone

The Issue: Presence of Foreign substance - potential presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 26, 2026· F.H. INVESTMENTS, Inc. (dba Asteria Health)

Recalled Item: Testosterone

The Issue: Presence of Foreign substance - potential presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 26, 2026· F.H. INVESTMENTS, Inc. (dba Asteria Health)

Recalled Item: ESTRADIOL

The Issue: Presence of Foreign substance - potential presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 26, 2026· F.H. INVESTMENTS, Inc. (dba Asteria Health)

Recalled Item: Testosterone

The Issue: Presence of Foreign substance - potential presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 26, 2026· F.H. INVESTMENTS, Inc. (dba Asteria Health)

Recalled Item: ESTRADIOL

The Issue: Presence of Foreign substance - potential presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 26, 2026· F.H. INVESTMENTS, Inc. (dba Asteria Health)

Recalled Item: Testosterone 200mg

The Issue: Presence of Foreign substance - potential presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 26, 2026· F.H. INVESTMENTS, Inc. (dba Asteria Health)

Recalled Item: ESTRADIOL

The Issue: Presence of Foreign substance - potential presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund